As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

Success with a smart VF is less about the screens and more about how people interact with the data and each other.

Lantern Pharma (LTRN) announced the presentation of clinical data from its ongoing Phase 1 trial of LP-284 at the 25th Annual Lymphoma, Leukemia & ...

Clarity Pharmaceuticals Ltd. ( ($AU:CU6) ) has provided an announcement. Clarity Pharmaceuticals Ltd responded to an ASX inquiry regarding the ...

Swiss exports to the United States rebounded sharply in September, with pharmaceutical companies ramping up their shipments ...

Experts say that sectors such as pharma, energy and infra give banks the opportunity to get “hard collateral” (such as land, ...

New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...

In a new white paper, Havas Lynx lays out ways in which pharma marketers can—and should, according to the health comms agency ...

Synthetic audience testing is here to stay, but its value depends on how it’s done. Resonance Read introduces a more behaviorally precise, evidence-based way forward.

However, if pharma manufacturers aren’t using RWD in a strategic way, they’ll miss out on its full potential. And with that, they risk costly inefficiencies, slowing down their time to bring therapies ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study ...

CStone Pharmaceuticals ( OTCPK:CSPHF) Discusses CS2009 Data Interpretation and Future Clinical Development Strategy October 20, 2025 9:00 AM EDT ...